Uros Medic is finally slated to make his long-awaited professional appearance in his native Serbia. The UFC confirmed last month that it will host its inaugural event in the Balkan nation, with a Fight Night card dubbed “UFC Belgrade” scheduled for August 1 at the Belgrade Arena. This announcement immediately fueled speculation that local stars like Medic would be prominently featured, especially given his vocal advocacy for the UFC to bring an event to Serbia.
Now, “The Doctor” is set to bring this vision to life, securing a homecoming fight in the main event of a historic night for the promotion.
Uros Medic vs. Daniel Rodriguez Set for UFC Belgrade Main Event
On Monday, the mixed martial arts organization revealed that Uros Medic will headline UFC Belgrade in a welterweight showdown against fellow Dana White’s Contender Series alum, Daniel Rodriguez. The news of this matchup was initially broken by MMA journalist Marcel Dorff.
Medic enters this bout on the heels of a spectacular knockout victory over veteran Geoff Neal at UFC Houston in February, extending his current win streak to three consecutive fights. The 33-year-old Serbian fighter’s last defeat occurred in January 2025, when he was knocked out in the first round by Punahele Soriano at UFC Vegas 101.
“The Doctor” boasts a 7-3 record within the UFC, notably featuring knockout wins against Muslim Salikhov, Gilbert Urbina, and Tim Means. Medic’s professional record stands at an impressive 13-3 overall, with every single one of his victories achieved by way of finish.
Meanwhile, Rodriguez was last in action at UFC 318 in July 2025, where he secured a unanimous decision victory over Kevin Holland. Following this win, the 39-year-old Californian later disclosed his detention in Mexico for several months after allegedly being found with marijuana while crossing the border.
“D-Rod” is currently on a three-fight winning streak and holds a 10-4 record in the UFC. His overall professional record is 20-5, with significant wins against notable opponents such as Santiago Ponzinibbio, Li Jingliang, and Kevin Lee.
